Where acceptance is all there is!
If you or someone you know has Medicare Part D and has been denied, delayed, or restricted coverage for an FDA-approved alopecia areata medication, NAAF wants to hear about it.
This includes coverage issues involving Olumiant, Litfulo, or Leqselvi — even if the medication was eventually approved after an appeal.
NAAF is collecting this…
ContinueAdded by Cheryl, Co-founder on August 26, 2026 at 9:41pm — No Comments
Any mention of products and services on Alopecia World is for informational purposes only; it does not imply a recommendation or endorsement by Alopecia World. Nor should any statement or representation on this site be construed as professional, medical or expert advice, or as pre-screened or endorsed by Alopecia World. Alopecia World is not responsible or liable for any of the views, opinions or conduct, online or offline, of any user or member of Alopecia World.
© 2026 Created by Alopecia World.
Powered by